Company intelligence / Profile preview

Omnica Biotech

Ownership: Private
Development stage: Other

Overview

Omnica Biotech is an active scientific advisory and R&D consulting firm specializing in central nervous system (CNS) pharmacology. The company supports clients through all stages of drug or medical product development—from lead selection to preclinical studies and clinical trials—and offers regulatory submission support. It also develops educational materials for healthcare professionals and patients in neuropsychiatry, psychedelic medicine, mental health, wellness/longevity, precision medicine, and cannabis science. No proprietary clinical results or pipeline programs are reported.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Small moleculeBiologicPsychedelic medicineCannabis-based products
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Omnica Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omnica Biotech.

Explore the full profile